Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$0.28 - $1.16 $1,400 - $5,800
5,000 Added 25.0%
25,000 $8,000
Q1 2024

May 10, 2024

BUY
$1.06 - $1.67 $5,300 - $8,350
5,000 Added 33.33%
20,000 $23,000
Q2 2023

Aug 02, 2023

BUY
$1.14 - $1.95 $2,280 - $3,900
2,000 Added 15.38%
15,000 $27,000
Q1 2023

May 08, 2023

BUY
$1.2 - $2.19 $1,200 - $2,190
1,000 Added 8.33%
13,000 $17,000
Q4 2022

Jan 25, 2023

BUY
$1.63 - $3.52 $19,560 - $42,240
12,000 New
12,000 $0

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Beaumont Financial Advisors, LLC Portfolio

Follow Beaumont Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Advisors, LLC with notifications on news.